4:50 PM
Mar 27, 2017
 |  BC Extra  |  Financial News

Ionis lipid spinout Akcea targets $100M IPO

Editor's Note: This article was updated on Mar 28, 2017 at 3:54 PM PDT

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) plans to spin out subsidiary Akcea Therapeutics Inc. in an IPO in which it would raise up to $100 million, according to a regulatory filing. Concurrently, partner Novartis AG (NYSE:NVS; SIX:NOVN) is to invest $50 million in Akcea via a separate private placement at the IPO...

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >